A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic neuropathy (LHON). The study was conducted in collaboration with the Seoul National University College of Veterinary Medicine and Edgene Co., Ltd.
Source: https://medicalxpress.com/news/2026-02- ... itary.html
-
Translation